Antibiotics Use and Stewardship in Hospitals and Outpatient Care Facilities, 2nd Edition
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiotics Use and Antimicrobial Stewardship".
Deadline for manuscript submissions: 31 December 2024 | Viewed by 90
Special Issue Editors
Interests: clinical trials; preclinical lab work including animal and invitro models; data collection and analysis; contributing to development; optimization and stewardship for antibacterial agents
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The first edition of the Special Issue “Antibiotics Use and Stewardship in Hospitals and Outpatients Care Facilities” was published in 2023. It is a successful Special Issue with 19 papers and has encouraged us to open a second edition on the same topic.
As a continuation of the Special Issue published in 2023, the second edition will also explore the following fields:
- Assessment of the prevalence and treatment outcomes of resistant phenotypes (ESBL, CRE, MRSA, and VRSA) in hospitalized patients;
- Prevalence of concurrent infections, treatment outcome assessment, and ASP activities in special patient groups (immunocompromised patients; COVID-19 patients; pregnant women; neonates and pediatric patients; patients with genetic blood coagulopathy diseases (thalassemia, sickle cell, G6PD, etc.);
- Impact of implementing rapid diagnostic tools for antimicrobial susceptibility testing;
- Impact of implementing ASP strategies in outpatient and inpatient health facilities on infections, resistance patterns, healthcare costs, morbidity, and mortality rates;
- Impact of the implementation of pre- and post-operative prophylaxis protocols;
- Practices that improve antimicrobial stewardship and optimize outcomes;
- Discovery of new antimicrobials or repurposing of existing antimicrobials.
Dr. Islam M. Ghazi
Prof. Dr. Ahmed El Yazbi
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antimicrobial stewardship
- novel antibiotics
- microbial resistance
- optimizing treatment
- pharmacokintics/pharmacodynamics
